Invention Grant
- Patent Title: Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
-
Application No.: US17228301Application Date: 2021-04-12
-
Publication No.: US11617760B2Publication Date: 2023-04-04
- Inventor: Zhennan Lai , Jeffrey A. Galvin
- Applicant: American Gene Technologies International Inc.
- Applicant Address: US MD Rockville
- Assignee: American Gene Technologies International Inc.
- Current Assignee: American Gene Technologies International Inc.
- Current Assignee Address: US MD Rockville
- Agency: DLA Piper LLP (US)
- Main IPC: A61K31/7088
- IPC: A61K31/7088 ; C07K14/47 ; C12N15/86 ; C12N15/113 ; A61K48/00

Abstract:
The present application discloses a lentiviral transfer system which includes: (i) a self-inactivating transfer vector comprising: multiple gene units, wherein each gene unit includes a heterologous nucleic acid sequence operably linked to a regulatory nucleic acid sequence; and (ii) a helper construct which lacks a 5′ LTR, wherein the 5′ LTR has been replaced with a heterologous promoter, in which the helper construct further comprises: a lentiviral env nucleic acid sequence containing a deletion, wherein the deleted env nucleic acid sequence does not produce functional env protein; and a packaging signal contains a deletion, wherein the deleted packaging signal is nonfunctional.
Public/Granted literature
- US20210401868A1 SAFE LENTIVIRAL VECTORS FOR TARGETED DELIVERY OF MULTIPLE THERAPEUTIC MOLECULES Public/Granted day:2021-12-30
Information query